Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids
- PMID: 15662970
- DOI: 10.1007/s11060-004-9161-7
Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids
Abstract
During photodynamic therapy (PDT) both normal and pathological brain tissue, in close proximity to the light source, can experience significant temperature increases. The purpose of this study was to investigate the anti-tumor effects of concurrent 5-aminolevulinic acid (ALA)-mediated PDT and hyperthermia (HT) in human and rat glioma spheroids. Human or rat glioma spheroids were subjected to PDT, HT, or a combination of the two treatments. Therapies were given concurrently to simulate the conditions that will occur during patient PDT. Predictions of diffusion theory suggest that brain tissue immediately adjacent to a spherical light applicator may experience temperature increases approaching 8 degrees C for laser input powers of 2 W. In the in vitro model employed here, HT had no effect on spheroid survival at temperatures below 49 degrees C, while sub-threshold fluence PDT results in only modest decrease in survival. HT (40-46 degrees C) and PDT interact in a synergistic manner if the two treatments are given concurrently. The degree of synergism increases with increasing temperature and light fluence. Apoptosis is the primary mode of cell death following both low-fluence rate PDT and combined HT + PDT.
Similar articles
-
Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy.Neurol Res. 2011 Sep;33(7):739-46. doi: 10.1179/1743132810Y.0000000001. Neurol Res. 2011. PMID: 21756554
-
Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.J Neurooncol. 2003 May;62(3):243-50. doi: 10.1023/a:1023362011705. J Neurooncol. 2003. PMID: 12777075
-
Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.Lasers Surg Med. 2006 Dec;38(10):939-45. doi: 10.1002/lsm.20445. Lasers Surg Med. 2006. PMID: 17163479
-
Multicell tumor spheroids in photodynamic therapy.Lasers Surg Med. 2006 Jun;38(5):555-64. doi: 10.1002/lsm.20350. Lasers Surg Med. 2006. PMID: 16788918 Review.
-
Repetitive photodynamic therapy of malignant brain tumors.J Environ Pathol Toxicol Oncol. 2006;25(1-2):261-79. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.170. J Environ Pathol Toxicol Oncol. 2006. PMID: 16566723 Review.
Cited by
-
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.J Control Release. 2012 Dec 10;164(2):192-204. doi: 10.1016/j.jconrel.2012.04.045. Epub 2012 May 18. J Control Release. 2012. PMID: 22613880 Free PMC article. Review.
-
Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.Cancers (Basel). 2021 Feb 2;13(3):580. doi: 10.3390/cancers13030580. Cancers (Basel). 2021. PMID: 33540759 Free PMC article. Review.
-
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas.J Neurooncol. 2019 Feb;141(3):595-607. doi: 10.1007/s11060-019-03103-4. Epub 2019 Jan 18. J Neurooncol. 2019. PMID: 30659522 Free PMC article. Review.
-
Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.J Neurooncol. 2007 Mar;82(1):49-60. doi: 10.1007/s11060-006-9252-8. Epub 2006 Sep 27. J Neurooncol. 2007. PMID: 17004102
-
Synergistic chemotherapy by combined moderate hyperthermia and photochemical internalization.Biomed Opt Express. 2016 Mar 14;7(4):1240-50. doi: 10.1364/BOE.7.001240. eCollection 2016 Apr 1. Biomed Opt Express. 2016. PMID: 27446650 Free PMC article.